Chemical Structure (Invokana 01)
Invokana Tablet, Film Coated
Product Images NDC 50458-140
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Invokana (NDC 50458-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Invokana 02)
Figure 2 (Invokana 03)
Figure 3 (Invokana 04)
Figure 4 (Invokana 05)
This appears to be a statistical table that compares the number of events experienced by subjects using Canvas and Placebo over a period of weeks. There are also confidence interval values provided. However, it is difficult to provide a more detailed description or interpretation without additional context or information.*
Principal Display Panel (100 mg Tablet Bottle Label)
Principal Display Panel (300 mg Tablet Bottle Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
